Financial terms were not disclosed.
The Parisian start-up specializing in artificial intelligence (AI), Iktos, has just announced the signing of a collaboration agreement with the American giant Pfizer.
The lab will therefore use Iktos’ generative AI technology in a number of small molecule research programs for the design de novo drugs.
” In […]